secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azitra, Inc. (AZTR)
CIK:        0001701478
Form:       8-K
Filed at:   2026-06-04T20:10:29+00:00
Accession:  0001493152-26-027270
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azitra adjourns 2026 annual meeting; only 17% of shares voted, needs 33.3% quorum
--------------------------------------------------------------------------------

- Meeting reconvened to June 15, 2026 at 11:00 a.m. ET; record date remains April 24, 2026.
- Proxies received represented approx. 17% of outstanding shares; quorum requires 33⅓%.
- No changes to proposals; stockholders can vote by mail, Internet, or phone until June 15 at 10:59 a.m. ET.
- Company is a clinical-stage biopharma focused on precision dermatology; lead program ATR-12 for Netherton syndrome.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1701478/000149315226027270/0001493152-26-027270-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1701478/000149315226027270/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-027270

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer